Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could virtual reality help kids with brain disorders learn and move better?

NCT ID NCT07426315

Symptom relief Sponsor: IRCCS Centro Neurolesi Bonino Pulejo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether immersive virtual reality (VR) therapy can improve cognitive, motor, and social skills in children aged 8 to 18 with ADHD, autism, or cerebral palsy. Participants will use the CAREN VR system, which provides interactive exercises with visual, sound, and touch feedback, while a control group receives standard therapies. The goal is to see if VR makes rehabilitation more engaging and effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Immersive virtual reality therapy using the CAREN system
What this could lead to
If it works, this could offer a more engaging and effective rehabilitation option for children with neurodevelopmental disorders, potentially improving attention, motor skills, and social interaction.
What could go wrong
This is a relatively small, early-stage study (108 participants) testing a novel approach, so results may not be conclusive or generalizable. The therapy is behavioral, not a cure, and benefits may vary widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 108 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children and adolescents aged 8 to 18 years * Diagnosis of one of the following neurodevelopmental disorders: * Attention Deficit Hyperactivity Disorder (ADHD) * Autism Spectrum Disorder (ASD) * Cerebral Palsy (CP) * Ability to understand and comply with instructions for the intervention * Adequate cognitive, motor, and social skills to participate in the rehabilitation program * Informed consent obtained from a parent or legal guardian Exclusion Criteria: * Children and adolescents younger than 8 or older than 18 years * Severe cognitive impairments or intellectual disabilities that prevent participation in the rehabilitation program * Diagnosis of conditions not related to the target neurodevelopmental disorders, such as: * Major psychiatric disorders (e.g., severe depression, schizophrenia) * Neurological disorders not included in the study (e.g., epilepsy) * Severe motor impairments that prevent interaction with the virtual reality platform * Uncontrolled medical conditions (e.g., severe cardiovascular, respiratory, or endocrine diseases) * Lack of informed consent from a parent or legal guardian * Participation in another intervention or study that may interfere with the rehabilitation program * Behavioral issues or extreme anxiety that make it impossible to follow instructions or interact with the virtual reality system

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit hyperactivity disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit-hyperactivity disorder autism spectrum disorder cerebral palsy neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neurodevelopmental disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • IRCCS Neurolesi Bonino Pulejo

    RECRUITING

    Messina, Messina, 98124, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.